These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
784 related articles for article (PubMed ID: 9122728)
61. Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma). Mannucci PM; Cattaneo M; Canciani MT; Maniezzo M; Vaglini M; Cascinelli N Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1413-7. PubMed ID: 2531669 [TBL] [Abstract][Full Text] [Related]
62. Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients? Capoluongo E; Paolillo C; Vendittelli F Br J Dermatol; 2014 Jul; 171(1):190-1. PubMed ID: 24397844 [No Abstract] [Full Text] [Related]
64. [Morphological studies of leukocyte long-term culture. 2. A new method for identification of proliferating tumor cells in peripheral blood]. Klehr NW; Bretz S; Pott C Z Hautkr; 1980 May; 55(9):588-601. PubMed ID: 6996368 [TBL] [Abstract][Full Text] [Related]
65. Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Michaelson JS; Cheongsiatmoy JA; Dewey F; Silverstein MJ; Sgroi D; Smith B; Tanabe KK Br J Cancer; 2005 Nov; 93(11):1244-9. PubMed ID: 16278668 [TBL] [Abstract][Full Text] [Related]
66. [In vitro study of peripheral blood with thymidine-3H in the diagnosis of melanoma of the skin]. Tolkacheva EN; Savvateeva ZhP; Agranat VZ Med Radiol (Mosk); 1976 Dec; 21(12):25-9. PubMed ID: 1025413 [No Abstract] [Full Text] [Related]
67. RE: Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients. Raimondi S; Johansson H; Gandini S J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 27092382 [No Abstract] [Full Text] [Related]
68. A rare case of circulating melanoma cells in peripheral blood. Bell RC; Morrison T Blood; 2019 Oct; 134(16):1359. PubMed ID: 31698441 [No Abstract] [Full Text] [Related]
72. A clinical study of circulating tumor cells in malignant melanoma. ROMSDAHL MM; POTTER JF; MALMGREN RA; CHU EW; BRINDLEY CO; SMITH RR Surg Gynecol Obstet; 1960 Dec; 111():675-81. PubMed ID: 13743094 [No Abstract] [Full Text] [Related]
73. Essential Components of Melanoma Histopathological Reporting: The Surgical Oncologist's Perspective. Nurdjaja V; Yozu M; Mathy JA J Skin Cancer; 2018; 2018():9838410. PubMed ID: 29854464 [TBL] [Abstract][Full Text] [Related]
74. Detection of Occult Invasion in Melanoma In Situ. Rodic N; Glusac EJ JAMA Dermatol; 2017 Jun; 153(6):611. PubMed ID: 28384663 [No Abstract] [Full Text] [Related]
75. Detection of Occult Invasion in Melanoma in Situ-Reply. Chan MP; Fullen DR; Johnson TM JAMA Dermatol; 2017 Jun; 153(6):611-612. PubMed ID: 28384696 [No Abstract] [Full Text] [Related]
76. Management decisions for nodal metastasis from an unknown primary melanoma. Lee CC; Faries MB; Morton DL Am J Hematol Oncol; 2008 Jul; 7(7):306-308. PubMed ID: 21687815 [No Abstract] [Full Text] [Related]
77. Intracranial hemorrhagic metastases as the first manifestation of an occult melanoma. Reddy VU; Suneetha P; Shanthi V; Murali Mohan KV; Agrawal A South Asian J Cancer; 2015; 4(2):101-2. PubMed ID: 25992355 [No Abstract] [Full Text] [Related]
78. [Rejection antigens of tumors and specific immunotherapy of cancer]. Boon T; Lucas S Bull Mem Acad R Med Belg; 1996; 151(12):469-79. PubMed ID: 9491625 [TBL] [Abstract][Full Text] [Related]
79. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744 [TBL] [Abstract][Full Text] [Related]